RFC
SGMO

Russell Frank Company’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Russell Frank Company’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-76,760
Closed -$722K – 3027
2015
Q4 		$722K Buy
+76,760
New +$591K ﹤0.01% 2350
2014
Q3 		– Sell
-49,685
Closed -$634K – 2892
2014
Q2 		$634K Sell
49,685
-6,039
-11% -$86.9K ﹤0.01% 2247
2014
Q1 		$777K Buy
55,724
+7,396
+15% +$143K ﹤0.01% 2199
2013
Q4 		$680K Buy
48,328
+42,086
+674% +$485K ﹤0.01% 2227
2013
Q3 		$65K Sell
6,242
-49
-0.8% -$487 ﹤0.01% 3043
2013
Q2 		$49K Buy
+6,291
New +$54.9K ﹤0.01% 2872

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Russell Frank Company's SGMO Position: Q1 2016 in Review

Russell Frank Company sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2016, closing a stake of 76,760 shares — an estimated $722K sold.

Russell Frank Company first reported a position in SGMO in Q2 2013 and held it in 6 quarters. The position peaked at $777K in Q1 2014. 143 funds tracked by Wall St. Rank hold SGMO as of Q1 2016.

  • Russell Frank Company reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2016 after selling out during the quarter.
  • Russell Frank Company sold 76,760 SANGAMO THERAPEUTICS INC shares in Q1 2016, an estimated $722K.
  • Russell Frank Company first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 6 quarters.
  • Russell Frank Company's SANGAMO THERAPEUTICS INC position peaked at $777K in Q1 2014.
  • 143 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.